Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vaccitech Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11087
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), and other therapeutic infectious diseases indications. It utilizes T cell technology platform to develop its products. Vaccitech is a spin-off company from the University of Oxford’s Jenner Institute. The company works in partnership with Emergent BioSolutions, Oxford Sciences Innovation, Batavia Biosciences, Oxford Genetics and Oxford University Innovation to research and develop clinical programs for infectious diseases and cancers. Vaccitech is headquartered in Oxford, England, the UK.

Vaccitech Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vaccitech Raises USD27.4 Million in Series A Financing 10
Vaccitech Raises USD14.4 Million in Seed Financing Round 11
Licensing Agreements 12
Vaccitech Enters into Licensing Agreement with University of Oxford 12
Vaccitech Ltd – Key Competitors 13
Vaccitech Ltd – Key Employees 14
Vaccitech Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Strategy And Business Planning 16
Apr 19, 2018: Driven by rapid growth Oxford Sciences Innovation expands to The Oxford Science Park 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Vaccitech Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vaccitech Raises USD27.4 Million in Series A Financing 10
Vaccitech Raises USD14.4 Million in Seed Financing Round 11
Vaccitech Enters into Licensing Agreement with University of Oxford 12
Vaccitech Ltd, Key Competitors 13
Vaccitech Ltd, Key Employees 14

List of Figures
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaccitech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Agriterra Ltd (AGTA):企業の財務・戦略的SWOT分析
    Summary Agriterra Ltd (Agriterra) is a provider of agricultural investment and sustainable development solutions. The company provide products such as beef, maize, cocoa and palm oil. It offers business in the fields of beef that conducts cattle ranching, feedlot, abattoir operations and retail unit …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Newcrest Mining Limited:戦略・SWOT・企業財務分析
    Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Carlisle Companies Inc:企業の戦略・SWOT・財務情報
    Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Carlisle Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • WellCare Health Plans, Inc.:企業の戦略・SWOT・財務情報
    WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report Summary WellCare Health Plans, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ahimsa Industries Limited:戦略・SWOT・企業財務分析
    Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tethys Petroleum Ltd (TPL.H):企業の財務・戦略的SWOT分析
    Tethys Petroleum Ltd (TPL.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • UNIQA Ukraine:企業の戦略・SWOT・財務情報
    UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report Summary UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Egyptian Resorts Co:企業の戦略・SWOT・財務分析
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MRC Global Inc (MRC):企業の財務・戦略的SWOT分析
    MRC Global Inc (MRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bangchak Corporation PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bangchak Corporation PCL (Bangchak) is an integrated energy company. Its core business is petroleum refining, procuring crude oil from domestic and international sources and refining it into various petroleum products. The company’s major products include gasoline, gasohol, jet fuel, diesel, …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Pharmathen Global BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmathen Global BV (Pharmathen) is a pharmaceutical company with focus on the research and development of generics, active pharmaceutical ingredients (APIs), and finished formulations. Its vast product portfolio includes antibiotics, antimycotics, antivirals, antidiabetics and topical pain …
  • PT PLN (Persero):企業の戦略的SWOT分析
    PT PLN (Persero) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Unipack, Inc.:企業の戦略・SWOT・財務分析
    Unipack, Inc. - Strategy, SWOT and Corporate Finance Report Summary Unipack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dar Al Dawa Development & Investment Co Ltd (DADI):企業の財務・戦略的SWOT分析
    Dar Al Dawa Development & Investment Co Ltd (DADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Bayer AG (BAYN)-製薬・医療分野:企業M&A・提携分析
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, oncology, hematology, ophthalmology, infection and other indicat …
  • British Polythene Industries PLC:企業の戦略・SWOT・財務情報
    British Polythene Industries PLC - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆